Realeve Team
Patrick Balsmann
Regulatory executive with over 25 years’ experience in regulatory/clinical affairs and quality assurance. Responsible for regulatory strategies for U.S. and international medical device registrations. History of successful submission approvals for medical products including ultrasound, orthopedic sports medicine & trauma, and ophthalmic products.
Advisory Board
Dr. Ali R. Rezai, M.D.
Dr. Rezai is an internationally renown neurosurgeon advancing the use of brain chip implants in deep brain stimulation and neuromodulation to treat Parkinson’s disease, obsessive-compulsive disorder, Alzheimer’s disease and traumatic brain injury. Rezai led a surgical team using a chip implant to decode and transmit signals from the motor cortex of a patient’s brain to bypass spinal injury and restore limb movement, giving a paralyzed man the use of his hand. This surgical procedure presented a technological and breakthrough in neural engineering as the first ever account of limb reanimation.
Anthony Caparso
Over 20 years of implantable and non-implantable neuromodulation technology experience, including, device design and development, clinical research, basic neurophysiological research, company operations and multiple c-level positions, including President and CEO at Aurea Medical and Chief Scientist at Autonomic Technologies. Named inventor on over 100 patents, and author on over 30 peer review scientific articles, abstracts, and book chapters
Dr. Supornchai Kongpatanakul
Dr. Supornchai Kongpatanakul works in Department of Pharmacology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand, is a well-known researcher in field of Bioequivalence & Bioavailability. One of his renowned work is Bioequivalence Study of 10 mg Olanzapine Tablets in Healthy Thai Volunteers.
Dr. Stewart J. Tepper
He is Director of the Dartmouth Headache Clinic in the Department of Neurology of Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Dr Tepper is Editor-in-Chief of the journal Headache Currents and Associate Editor for the journal Headache and has published over 320 peer-reviewed manuscripts, editorials, and books, including The Cleveland Clinic Manual of Headache Therapy, Second Edition (Springer, 2014). He has been Co-Director of the Scottsdale Headache Symposium course of the American Headache Society from 2008 to the present and was Director of the Headache Therapy course for the American Academy of Neurology 2009-2011. Dr Tepper received his undergraduate degree in the study of the nervous system/Psychobiology from Yale College and attended Cornell University Medical College. He completed his Neurology residency at Harvard, and has been Board-certified in Headache Medicine since 2006.
Michael J. Lang, MD
Michael J. Lang, MD is a vascular and endovascular neurosurgeon who specializes in treatment of vessel diseases of the brain, including aneurysms, stroke, carotid artery stenosis, arteriovenous malformations and fistulas, cavernomas, and intracerebral hemorrhage at the University of Pittsburgh. He performs both minimally invasive endovascular and traditional open & skull base surgery, allowing a comprehensive approach in the treatment of cerebrovascular disease. He also has subspecialty training in functional/epilepsy neurosurgery. Dr. Lang completed his undergraduate work at the University of Wisconsin. He received his medical degree from Ohio State University, graduating with honors. Dr. Lang completed his neurosurgical residency and fellowships in both endovascular neurosurgery and functional & epilepsy surgery at Thomas Jefferson University. He then completed the prestigious fellowship in open cerebrovascular and skull base surgery at the Barrow Neurological Institute with extensive training in cerebral bypass surgery and removal of vascular lesions of the brainstem.